These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 25978431)
41. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway. Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907 [TBL] [Abstract][Full Text] [Related]
42. NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma. Galietta A; Gunby RH; Redaelli S; Stano P; Carniti C; Bachi A; Tucker PW; Tartari CJ; Huang CJ; Colombo E; Pulford K; Puttini M; Piazza RG; Ruchatz H; Villa A; Donella-Deana A; Marin O; Perrotti D; Gambacorti-Passerini C Blood; 2007 Oct; 110(7):2600-9. PubMed ID: 17537995 [TBL] [Abstract][Full Text] [Related]
43. The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma. Wang P; Zhang JD; Wu F; Ye X; Sharon D; Hitt M; McMullen TP; Hegazy SA; Gelebart P; Yang J; Ma Y; Lai R Cell Signal; 2012 Oct; 24(10):1955-63. PubMed ID: 22743134 [TBL] [Abstract][Full Text] [Related]
44. Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA). Ouyang T; Bai RY; Bassermann F; von Klitzing C; Klumpen S; Miething C; Morris SW; Peschel C; Duyster J J Biol Chem; 2003 Aug; 278(32):30028-36. PubMed ID: 12748172 [TBL] [Abstract][Full Text] [Related]
45. Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas. Bonvini P; Zorzi E; Mussolin L; Pillon M; Romualdi C; Peron M; d'Amore ES; Lamant L; Rosolen A Leukemia; 2012 Jun; 26(6):1375-82. PubMed ID: 22289917 [TBL] [Abstract][Full Text] [Related]
46. Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma. K Singh V; Werner S; Hackstein H; Lennerz V; Reiter A; Wölfel T; Damm-Welk C; Woessmann W Clin Exp Immunol; 2016 Oct; 186(1):96-105. PubMed ID: 27414060 [TBL] [Abstract][Full Text] [Related]
47. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631 [TBL] [Abstract][Full Text] [Related]
48. De novo generation of the NPM-ALK fusion recapitulates the pleiotropic phenotypes of ALK+ ALCL pathogenesis and reveals the ROR2 receptor as target for tumor cells. Babin L; Darchen A; Robert E; Aid Z; Borry R; Soudais C; Piganeau M; De Cian A; Giovannangeli C; Bawa O; Rigaud C; Scoazec JY; Couronné L; Veleanu L; Cieslak A; Asnafi V; Sibon D; Lamant L; Meggetto F; Mercher T; Brunet E Mol Cancer; 2022 Mar; 21(1):65. PubMed ID: 35246138 [TBL] [Abstract][Full Text] [Related]
49. Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase. Tartari CJ; Gunby RH; Coluccia AM; Sottocornola R; Cimbro B; Scapozza L; Donella-Deana A; Pinna LA; Gambacorti-Passerini C J Biol Chem; 2008 Feb; 283(7):3743-50. PubMed ID: 18070884 [TBL] [Abstract][Full Text] [Related]
50. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression. Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Younes A Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164 [TBL] [Abstract][Full Text] [Related]
51. Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK. Uchihara Y; Ueda F; Tago K; Nakazawa Y; Ohe T; Mashino T; Yokota S; Kasahara T; Tamura H; Funakoshi-Tago M PLoS One; 2017; 12(8):e0183003. PubMed ID: 28806414 [TBL] [Abstract][Full Text] [Related]
52. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Amin HM; McDonnell TJ; Ma Y; Lin Q; Fujio Y; Kunisada K; Leventaki V; Das P; Rassidakis GZ; Cutler C; Medeiros LJ; Lai R Oncogene; 2004 Jul; 23(32):5426-34. PubMed ID: 15184887 [TBL] [Abstract][Full Text] [Related]
53. A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. Fawal M; Armstrong F; Ollier S; Dupont H; Touriol C; Monsarrat B; Delsol G; Payrastre B; Morello D Blood; 2006 Oct; 108(8):2780-8. PubMed ID: 16835382 [TBL] [Abstract][Full Text] [Related]
54. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK Shi W; George SK; George B; Curry CV; Murzabdillaeva A; Alkan S; Amin HM Mol Oncol; 2017 Sep; 11(9):1189-1207. PubMed ID: 28557340 [TBL] [Abstract][Full Text] [Related]
55. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Desjobert C; Renalier MH; Bergalet J; Dejean E; Joseph N; Kruczynski A; Soulier J; Espinos E; Meggetto F; Cavaillé J; Delsol G; Lamant L Blood; 2011 Jun; 117(24):6627-37. PubMed ID: 21471522 [TBL] [Abstract][Full Text] [Related]